These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan. Van de Kar LD; Urban JH; Richardson KD; Bethea CL Neuroendocrinology; 1985 Oct; 41(4):283-8. PubMed ID: 2931613 [TBL] [Abstract][Full Text] [Related]
5. Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in rats. Aulakh CS; Haass M; Zohar J; Wozniak KM; Hill JL; Murphy DL Pharmacol Biochem Behav; 1989 Jan; 32(1):37-42. PubMed ID: 2734349 [TBL] [Abstract][Full Text] [Related]
6. Differential effect of clomipramine treatment on m-chlorophenylpiperazine-induced increases in plasma prolactin and corticosterone in rats. Wozniak KM; Aulakh CS; Hill JL; Murphy DL Pharmacol Biochem Behav; 1989 May; 33(1):265-7. PubMed ID: 2780783 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs. Aulakh CS; Hill JL; Murphy DL Eur J Pharmacol; 1993 Aug; 240(1):85-8. PubMed ID: 8405126 [TBL] [Abstract][Full Text] [Related]
8. Differential effect of short- and long-term lithium treatment on m-CPP-induced neuroendocrine changes in rats. Aulakh CS; Hill JL; Murphy DL Neuroendocrinology; 1993 May; 57(5):869-74. PubMed ID: 8413823 [TBL] [Abstract][Full Text] [Related]
9. Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline. Aulakh CS; Hill JL; Wozniak KM; Murphy DL Psychopharmacology (Berl); 1988; 95(3):313-7. PubMed ID: 3137616 [TBL] [Abstract][Full Text] [Related]
11. The effect of d-fenfluramine on anterior pituitary hormone release in the rat: in vivo and in vitro studies. Serri O; Rasio E Can J Physiol Pharmacol; 1987 Dec; 65(12):2449-53. PubMed ID: 3449200 [TBL] [Abstract][Full Text] [Related]
12. Effect of lithium on the prolactin response to D-fenfluramine in healthy subjects. Power AC; Dorkins CE; Cowen PJ Biol Psychiatry; 1993 Jun 1-15; 33(11-12):801-5. PubMed ID: 8373918 [TBL] [Abstract][Full Text] [Related]
13. In vivo correlates of central serotonin function after high-dose fenfluramine administration. Baumann MH; Ayestas MA; Rothman RB Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672 [TBL] [Abstract][Full Text] [Related]
14. Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated rats. Fuller RW; Snoddy HD; Clemens JA Pharmacol Res Commun; 1981 Mar; 13(3):275-80. PubMed ID: 7208571 [No Abstract] [Full Text] [Related]
15. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats. Butterweck V; Winterhoff H; Herkenham M Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469 [TBL] [Abstract][Full Text] [Related]
16. Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients. Shapira B; Reiss A; Kaiser N; Kindler S; Lerer B J Affect Disord; 1989; 16(1):1-4. PubMed ID: 2521644 [TBL] [Abstract][Full Text] [Related]
17. Corticosterone and prolactin response to TFMPP in rats during repeated antidepressant administration. Poland RE; Frazer A J Pharm Pharmacol; 1991 Jan; 43(1):54-6. PubMed ID: 1676062 [TBL] [Abstract][Full Text] [Related]
18. Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats. Appel NM; Owens MJ; Culp S; Zaczek R; Contrera JF; Bissette G; Nemeroff CB; De Souza EB Endocrinology; 1991 Jun; 128(6):3237-46. PubMed ID: 1645265 [TBL] [Abstract][Full Text] [Related]
19. Effect of antidepressants, lithium and electroconvulsive treatment on rat serum prolactin levels. Meltzer HY; Simonovic M; Sturgeon RD; Fang VS Acta Psychiatr Scand Suppl; 1981; 290():100-21. PubMed ID: 6971560 [TBL] [Abstract][Full Text] [Related]
20. Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats. Aulakh CS; Mazzola-Pomietto P; Hill JL; Murphy DL J Pharmacol Exp Ther; 1994 Oct; 271(1):143-8. PubMed ID: 7965707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]